Crossmark

Development of imaging protocol and radiomics-based nomogram for assessing lesion reversibility in connective tissue disease-associated interstitial lung disease

Crossref DOI link: https://doi.org/10.1186/s12880-026-02191-9

Published Online: 2026-01-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Ying

Zhang, Feng

Wu, Huawei

Wang, Yu

Yu, Xiao

Lin, Shusen

Yu, Ye

Wei, Jiaxu

Zhou, Yan
License Information

Text and Data Mining valid from 2026-01-29

Version of Record valid from 2026-02-20
More Information

Article History

Received: 18 August 2024

Accepted: 22 January 2026

First Online: 29 January 2026

Declarations

:

: Ethics approval (No. LY2023-019-B) was granted by the institutional review board (IRB) of Shanghai Jiaotong University, School of Medicine, Renji Hospital. The IRB waived informed consent requirement for this retrospective study. We adhered to China’s Regulations on Ethical Review of Biomedical Research and relevant guidelines, including the Guidelines for Ethical Review of Biomedical Research Involving Human Subjects, and the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below